ENTRY       D09996                      Drug
NAME        Vemurafenib (JAN/USAN/INN);
            Zelboraf (TN)
PRODUCT     ZELBORAF (Genentech)
FORMULA     C23H18ClF2N3O3S
EXACT_MASS  489.0725
MOL_WEIGHT  489.9221
CLASS       Antineoplastic
             DG03159  BRAF inhibitor
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01643  CYP2C9 inhibitor
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      Therapeutic category: 4291
            ATC code: L01EC01
            Product: D09996<JP/US>
EFFICACY    Antineoplastic, BRAF kinase inhibitor
  DISEASE   Melanoma (BRAF mutation positive) [DS:H00038]
            Erdheim-Chester disease (BRAF mutation positive) [DS:H02425]
TARGET      BRAF* [HSA_VAR:673v1] [HSA:673] [KO:K04365]
  PATHWAY   hsa04010(673)  MAPK signaling pathway
            hsa04012(673)  ErbB signaling pathway
            hsa05200(673)  Pathways in cancer
            hsa05218(673)  Melanoma
INTERACTION CYP inhibition: CYP1A2 [HSA:1544], CYP2C9 [HSA:1559]
            CYP induction: CYP3A4 [HSA:1576]
            Transporter inhibition: ABCB1 [HSA:5243]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
                 L01EC01 Vemurafenib
                  D09996  Vemurafenib (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Vemurafenib
                D09996  Vemurafenib (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D09996  Vemurafenib (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG03159  BRAF inhibitor
               D09996  Vemurafenib
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               D09996  Vemurafenib
              DG01643  CYP2C9 inhibitor
               D09996  Vemurafenib
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                D09996  Vemurafenib
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D09996  Vemurafenib
            Drug classes [BR:br08332]
             Antineoplastic
              DG03159  BRAF inhibitor
               D09996  Vemurafenib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               TKL group
                BRAF* [HSA_VAR:673v1]
                 D09996  Vemurafenib (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09996
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09996
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09996
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09996
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09996
             Drug transporters
              D09996
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D09996
DBLINKS     CAS: 918504-65-1
            PubChem: 135626717
            ChEBI: 63637
            PDB-CCD: 032
            LigandBox: D09996
ATOM        33
            1   C8x C    14.3500  -17.7100
            2   C8y C    14.3500  -19.1100
            3   C8x C    15.5624  -19.8100
            4   C8x C    16.7749  -19.1100
            5   C8y C    16.7749  -17.7100
            6   C8x C    15.5624  -17.0100
            7   X   Cl   13.1376  -19.8100
            8   C8y C    18.0060  -16.9990
            9   C8x C    19.2112  -17.6947
            10  C8y C    20.4235  -16.9946
            11  C8y C    20.4235  -15.5946
            12  N5x N    19.2183  -14.8989
            13  C8x C    18.0059  -15.5990
            14  C8y C    21.7551  -17.4271
            15  C8x C    22.5779  -16.2945
            16  N4x N    21.7549  -15.1619
            17  C5a C    21.7551  -18.8271
            18  O5a O    20.5527  -19.5214
            19  C8y C    22.9799  -19.5343
            20  C8y C    22.9799  -20.9299
            21  C8y C    24.1923  -21.6299
            22  C8x C    25.4047  -20.9300
            23  C8x C    25.4048  -19.5344
            24  C8y C    24.1924  -18.8344
            25  X   F    24.1924  -17.4303
            26  X   F    21.7525  -21.6385
            27  N1b N    24.1922  -23.0297
            28  S4a S    25.4254  -23.7420
            29  C1b C    26.6314  -23.0458
            30  C1b C    27.8134  -23.7284
            31  C1a C    29.0075  -23.0389
            32  O3c O    24.4355  -24.7319
            33  O3c O    26.4154  -24.7319
BOND        36
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     2   7 1
            8     5   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15   10  14 1
            16   14  15 2
            17   15  16 1
            18   11  16 1
            19   14  17 1
            20   17  18 2
            21   17  19 1
            22   19  20 2
            23   20  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 2
            27   19  24 1
            28   24  25 1
            29   20  26 1
            30   21  27 1
            31   27  28 1
            32   28  29 1
            33   29  30 1
            34   30  31 1
            35   28  32 2
            36   28  33 2
///
